Central nervous system metastases in malignant melanoma

  • William A. Robinson
  • Kathleen Jobe
  • Richie Stevens
Part of the Cancer Treatment and Research book series (CTAR, volume 35)

Abstract

Of all the potential complications of malignant melanoma, none is more devastating or life threatening than the development of central nervous system (CNS) metastases. Once this occurs most patients are dead within a few months. While treatment may improve symptoms, it does little to prolong life in the majority of patients. Indeed, no effective methods of prevention or treatment have been devised to date, and these are urgently needed if we are to look forward to long-term survival and cure of such patients.

Keywords

Leukemia Corticosteroid Oncol Dexamethasone Melphalan 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baker GS Kernohan JW, Kiefer EJ: Metastatic tumors of the brain. Surg Clin N Am 31:1143–1145, 1972.Google Scholar
  2. 2.
    Chason JL, Walker FB, Landers JW: Metastatic carcinoma in the central nervous system and dorsal root ganglia: A prospective autopsy study. Cancer 16:781–787, 1963.PubMedCrossRefGoogle Scholar
  3. 3.
    Amer MH, AlSarraf M, Baker LH, Vaitkevicius VK: Malignant melanoma and central nervous system metastases Cancer 42:660–668, 1978.PubMedCrossRefGoogle Scholar
  4. 4.
    Madajewicz S, Karakousis C West CR, Caracandas J, Avellanosa AM: Malignant melanoma brain metastases: Review of Roswell Park Memorial Institute experience. Cancer 53:2550–2552, 1984.PubMedCrossRefGoogle Scholar
  5. 5.
    Stevens RN, Robinson WA: Brain metastases in malignant melanoma. Clinical Res 34:76A, 1986.Google Scholar
  6. 6.
    Crombie IK: Distribution of malignant melanoma on the body surface. Br J Cancer 43:842–849, 1981.PubMedCrossRefGoogle Scholar
  7. 7.
    Jobe KA, Stears JC, Robinson WA: Patterns of distribution of CNS metastases in malignant melanoma. Clinical Res 34:75A, 1986.Google Scholar
  8. 8.
    Batson OV: The vertebral vein system as a mechanism for the spread of metastases. Am J Roentgenology 715–718, 1942.Google Scholar
  9. 9.
    Kindt GW: The pattern of location of cerebral metastatic tumors. J Neurosurg 21:54–57, 1964.PubMedCrossRefGoogle Scholar
  10. 10.
    Carella RJ, Gelber R, Hendrickson F, Berry HC, Cooper JS: Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation therapy oncology brain metastases study I and II. Cancer 45:679–683, 1980.PubMedCrossRefGoogle Scholar
  11. 11.
    Habermaiz A, Fischer J: Radiation therapy of malignant melanoma experience with individual treatment doses. Cancer 38:2258–2262, 1976.CrossRefGoogle Scholar
  12. 12.
    Withers HR, Harter D: Radiotherapy in the management of malignant melanoma. In: Neoplasms of the skin and malignant melanoma. Chicago: Yearbook Medical Publishers, 1976.Google Scholar
  13. 13.
    Stridsklev IC, Hagen S, Klepp O: Radiation therapy for brain metastases from malignant melanoma. ACTA Radiol Onc 23:231–235, 1984.CrossRefGoogle Scholar
  14. 14.
    Thomas MR, Robinson WA, Glode LM, Dantas ME, Koeppler H, Morton N, Sutherland J: Treatment of advanced malignant melanoma with high dose chemotherapy and autologous bone marrow transplantation. Preliminary results-Phase I study. Am J of Clin Oncol 5:611–622, 1982.CrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1987

Authors and Affiliations

  • William A. Robinson
  • Kathleen Jobe
  • Richie Stevens

There are no affiliations available

Personalised recommendations